Ciphergen Biosystems Inc., of Fremont, Calif., received U.S. Patent No...Encoll Corp., of Fremont, Calif., received U.S. Patent No...NeuroNova AB, of Stockholm, Sweden, was assigned U.S. Patent No

ActivBiotics Inc., of Lexington, Mass., received U.S. Patent Nos...APT Pharmaceutical Inc., of Tucson, Ariz., received U.S. Patent No...Atrix Laboratories Inc., of Fort Collins, Colo., was assigned U.S. Patent No

Geron Corp., of Menlo Park, Calif., was granted U.S. Patent No...Vasogen Inc., of Mississauga, Ontario, received U.S. Patent No...Zyomyx Inc., of Hayward, Calif., was issued U.S. Patent No

Aphios Corp., of Woburn, Mass., was granted U.S. Patent No...Benitec Ltd., of Queensland, Australia, was issued U.S. Patent No...SuperGen Inc., of Dublin, Calif., was issued U.S. Patent No

Collegium Pharmaceutical Inc., of Hingham, Mass., was issued U.S. Patent No...DOR BioPharma Inc., of Lake Forest, Ill., said the University of Texas Southwestern Medical Center at Dallas was granted U.S. Patent No...Oncolytics Biotech Inc., of Calgary, Alberta, received U.S. Patent No

Sunol Molecular Corp., of Miramar, Fla., was issued U.S. Patent No...Inc., of Schlieren, Switzerland, received U.S. Patent No

Genome Therapeutics Corp., of Waltham, Mass., was issued U.S. Patent No...Ionix Pharmaceuticals Ltd., of Cambridge, UK, received U.S. Patent No...Inc., of Schlieren, Switzerland, received U.S. Patent No

Arena Pharmaceuticals Inc., of San Diego, was awarded U.S. Patent No...Avant Immunotherapeutics Inc., of Needham, Mass., was granted U.S. Patent No...Biomira Inc., of Edmonton, Alberta, said its U.S. Patent No

Curis Inc., of Cambridge, Mass., received U.S. Patent No...Gryphus Diagnostics LLC, of Birmingham, Ala., was issued U.S. Patent No...PBL Therapeutics, of Piscataway, N.J., was issued U.S. Patent No

Immunomedics Inc., of Morris Plains, N.J., was issued U.S. Patent No...Neurocrine Biosciences Inc., of San Diego, was issued U.S. Patent No...Vivus Inc., of Mountain View, Calif., was awarded U.S. Patent No

Advancis Pharmaceutical Corp., of Gaithersburg, Md., received U.S. Patent No...Akceli Inc., of Cambridge, Mass., was awarded U.S. Patent No...Entropin Inc., of Indio, Calif., was allowed U.S. Patent No

Diversa Corp., of San Diego, was granted U.S. Patent No...Lorus said the patent protects its intellectual property for its lead immunotherapeutic anticancer product, Virulizin, which is in a U.S.-based Phase III trial for pancreatic cancer...Provectus Pharmaceuticals Inc., of Knoxville, Tenn., received U.S. Patent No

OxiGene Inc., of Watertown, Mass., was awarded U.S. Patent No...Pacific Biometrics Inc., of Seattle, was granted U.S. Patent No...Targeted Genetics Corp., of Seattle, received U.S. Patent No

Cyntellect Inc., of San Diego, was awarded U.S. Patent No...Demegen Inc., of Pittsburgh, received U.S. Patent No...GenVec Inc., of Gaithersburg, Md., was issued U.S. Patent No

Advanced Biotherapy Inc., of Los Angeles, was issued U.S. Patent No...Amnis Corp., of Seattle, was issued U.S. Patent Nos...Chiron Corp., of Emeryville, Calif., was granted U.S. Patent No

Lorus Therapeutics Inc., of Toronto, said the U.S. Patent and Trademark Office allowed a patent to protect its intellectual property involving a lead anticancer target, the R1 component of ribonucleotide reductase...Lorus said the patent broadens the protection it obtained in a U.S...Oncolytics Biotech Inc., of Calgary, Alberta, received U.S. Patent No

BioCurex Inc., of Rancho Santa Margarita, Calif., was granted U.S. Patent No...CollaGenex Pharmaceuticals Inc., of Newtown, Pa., was granted U.S. Patent No...Esperion Therapeutics Inc., of Ann Arbor, Mich., was granted U.S. Patent No

Transkaryotic Therapies Inc., of Cambridge, Mass., was issued U.S. Patent No

Demegen Inc., of Pittsburgh, received U.S. Patent No...Egea Biosciences Inc., of San Diego, was granted U.S. Patent No...MethylGene Inc., of Montreal, received U.S. Patent 6,506,735 titled "Optimized Antisense Oligonucleotides Complementary to DNA Methyltransferase Sequences" covering optimized antisense oligonucleotides complementary to the DNA methyltransferase gene or its RNA transcript, including second-generation oligonucleotides, and methods for using such antisense oligonucleotides as